Required cookies

This website uses cookies necessary for its operation in order to provide the user with content and certain functionalities (e.g. language selection). You have no control over the use of these cookies.

Website visitor statistics

We collect visitor statistics on the use of the site. The data is not personally identifiable and is only stored in the Matomo visitor analytics tool managed by CSC.

By accepting visitor statistics, you allow Matomo to use various technologies, such as analytics cookies and web beacons, to collect statistics about your use of the site.

Change your cookie choices and read more about visitor statistics and cookies


FinnDiane, established by Professor Per-Henrik Groop in 1997, is a follow-up study participated in by almost 8,000 individuals with type 1 diabetes. The participants are recruited at 80 hospitals and health centres across Finland. It is one of the most extensive research materials on type 1 diabetes and associated complications in the world. Now, this material is used for sequencing the genome of 1,700 patients.

Genetic Epidemiologist Niina Sandholm at Folkhälsan Research Centre is involved in the FinnDiane research project, which is a collaboration project between University of Helsinki, Helsinki University Hospital (HUS) and Folkhälsan Research Center. According to Sandholm, the research results may help predict the risk of developing a condition or lead the way in developing new medicines.

– The broader goal of genetic research is to identify variants that affect the risk of developing a disease or directly cause a disease. This enables a better understanding of the causes of diabetic complications.

The ultimate goal is to learn to prevent and find cures to diseases associated with diabetes.

– Our aim is to read the entire DNA sequence of all patients. This will result in a huge amount of data, says Sandholm.

Genome sequencing on an exceptional scale

CSC provides the ePouta service for processing sensitive data. In the ePouta cloud service, virtual private servers operate on CSC’s computing platform under increased data security. The users receive dedicated cloud resources which are separated from CSC’s other computing environments. The FinnDiane research group uses the computing cluster of Institute for Molecular Medicine Finland (FIMM) which is connected to CSC’s sensitive data computing platform via the ePouta light path. By scaling the computing resources, the light path enables faster processing of the project data. In addition, the researchers have been allocated a remarkable amount of storage space to store the genomic data.

The research group has already sequenced the entire genomes of 600 patients. This study is one of the world’s first to sequence the entire genome this extensively with regard to a specific disease.

Read more on this initiative from ELIXIR web pages